Journal Article Summary

The article investigates dysphagia, or difficulty swallowing, in patients with amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease. Dysphagia is a significant concern in ALS as it can lead to serious complications such as malnutrition, dehydration, and aspiration pneumonia, which can ultimately affect survival. The study aims to understand how dysphagia impacts patient behavior, dietary adaptations, and the management of riluzole, the only drug approved for ALS treatment, particularly in patients with spinal and bulbar onset of the disease.

The researchers followed 145 ALS patients over a mean period of two years, conducting regular assessments of their swallowing function using fiberoptic endoscopic evaluation of swallowing (FEES) and spirometry. They found that the prevalence of dysphagia increased significantly during the study, with 85% of patients experiencing swallowing difficulties by the end of the follow-up. Notably, some patients were unaware of their dysphagia, which complicates management. The study also revealed that many patients modified their diets, with a shift towards pureed foods and an increase in the use of percutaneous endoscopic gastrostomy (PEG) for feeding, although a significant number refused recommended dietary changes.

Despite the findings, the study has limitations, including its retrospective nature and the potential for selection bias. It highlights the importance of regular swallowing assessments in ALS patients, as many may not recognize their swallowing difficulties. Patients and caregivers should discuss any swallowing issues with healthcare professionals to ensure appropriate dietary modifications and the safe administration of medications like riluzole, especially considering the challenges of swallowing pills. Regular evaluations can help prevent complications and improve quality of life for those affected by ALS.

Medical Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication. Always consult a licensed healthcare professional before using a medical device.

Article Cited

  1. Onesti Emanuela, Schettino Ilenia, Gori Maria Cristina, Frasca Vittorio, Ceccanti Marco, Cambieri Chiara, Ruoppolo Giovanni, Inghilleri Maurizio. Dysphagia in Amyotrophic Lateral Sclerosis: Impact on Patient Behavior, Diet Adaptation, and Riluzole Management. Frontiers in Neurology 2017. DOI: 10.3389/fneur.2017.00094. PMID: 28377742. PMCID: PMC5359548.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]